- Work address
-
C. Heymanslaan 10, ingang 38 - verdieping 1
9000 Gent - Beatrice.Lintermans@UGent.be
Show
Sort by
-
- Journal Article
- A1
- open access
Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies
-
Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia
-
- Journal Article
- A1
- open access
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma
-
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
-
Genetic characterization and therapeutic targeting of MYC translocated pediatric T-cell acute lymphoblastic leukemia
-
Fast generation of conditional ROSA26-based mouse models that recapitulate genomic events in human T-ALL
-
Targeting BET family proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
-
The combination of ABT-199 and JQ1 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
-
Targeting BET family proteins improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia
-
- Journal Article
- A1
- open access
KLHL12 promotes non-lysine ubiquitination of the dopamine receptors D-4.2 and D-4.4, but not of the ADHD-associated D-4.7 variant